A1AL3

(furan-2-yl)[4-({(5P)-5-(1H-indazol-4-yl)-2-[3-(morpholin-4-yl)propoxy]phenyl}methyl)piperazin-1-yl]methanone

Created:	2024-04-11
Last modified:	2024-09-18

Find Related PDB Entry
1 entries where A1AL3 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	74
Chiral Atom Count	0
Bond Count	79
Aromatic Bond Count	21

2D diagram of A1AL3

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(furan-2-yl)[4-({(5P)-5-(1H-indazol-4-yl)-2-[3-(morpholin-4-yl)propoxy]phenyl}methyl)piperazin-1-yl]methanone
Systematic Name (OpenEye OEToolkits)	furan-2-yl-[4-[[5-(1~{H}-indazol-4-yl)-2-(3-morpholin-4-ylpropoxy)phenyl]methyl]piperazin-1-yl]methanone
Formula	C₃₀ H₃₅ N₅ O₄
Molecular Weight	529.63
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(c1ccco1)N1CCN(CC1)Cc1cc(ccc1OCCCN1CCOCC1)c1cccc2[NH]ncc21
SMILES	CACTVS	3.385	O=C(N1CCN(CC1)Cc2cc(ccc2OCCCN3CCOCC3)c4cccc5[nH]ncc45)c6occc6
SMILES	OpenEye OEToolkits	2.0.7	c1cc(c2cn[nH]c2c1)c3ccc(c(c3)CN4CCN(CC4)C(=O)c5ccco5)OCCCN6CCOCC6
Canonical SMILES	CACTVS	3.385	O=C(N1CCN(CC1)Cc2cc(ccc2OCCCN3CCOCC3)c4cccc5[nH]ncc45)c6occc6
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(c2cn[nH]c2c1)c3ccc(c(c3)CN4CCN(CC4)C(=O)c5ccco5)OCCCN6CCOCC6
InChI	InChI	1.06	InChI=1S/C30H35N5O4/c36-30(29-6-2-16-39-29)35-12-10-34(11-13-35)22-24-20-23(25-4-1-5-27-26(25)21-31-32-27)7-8-28(24)38-17-3-9-33-14-18-37-19-15-33/h1-2,4-8,16,20-21H,3,9-15,17-19,22H2,(H,31,32)
InChIKey	InChI	1.06	SAFWOFNFKMPJAO-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	171936250

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.